CEO Jeffery Bacha Discusses DelMar’s VOL-083 Clinical Trials and the Major Milestones Ahead
26 sept. 2017 10h00 HE
|
DelMar Pharmaceuticals, Inc.
VANCOUVER, British Columbia , Sept. 26, 2017 (GLOBE NEWSWIRE) -- Jeffery Bacha, CEO of DelMar Pharmaceuticals Inc. (NASDAQ:DMPI) interviews on the Uptick Network Stock Day Podcast with host Everett...